...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.
【24h】

VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.

机译:VanE,粪肠球菌BM4405中一种新型的获得性糖肽耐药性。

获取原文
获取原文并翻译 | 示例
           

摘要

Enterococcus faecalis BM4405 was resistant to low levels of vancomycin (MIC, 16 microg/ml) and was susceptible to teicoplanin (MIC, 0.5 microg/ml). No PCR product was obtained when the total DNA of this clinical isolate was used as a template with primers specific for glycopeptide resistance genes vanA, vanB, vanC, and vanD. However, a 604-bp PCR fragment was obtained when V1 and V2 degenerate primers were used and total DNA was digested with HindIII as a template. The product was cloned and sequenced. The deduced amino acid sequence had greater identity (55%) with VanC than with VanA (45%), VanB (43%), or VanD (44%). This was consistent with the fact that BM4405 synthesized peptidoglycan precursors that terminated in D-serine residues. After induction with vancomycin, weak D,D-dipeptidase and penicillin-insensitive D,D-carboxypeptidase activities were detected in cytoplasmic extracts of BM4405, whereas a serine racemase activity was found in the membrane preparation. This new type of acquired glycopeptide resistance was named VanE.
机译:粪肠球菌BM4405对低水平的万古霉素(MIC,16微克/毫升)有抵抗力,对替考拉宁(MIC,0.5微克/毫升)敏感。当此临床分离株的总DNA用作模板时,没有糖分抗性基因vanA,vanB,vanC和vanD的特异性引物,则无法获得PCR产物。但是,当使用V1和V2简并引物并以HindIII为模板消化总DNA时,获得了604-bp PCR片段。克隆产物并测序。推导的氨基酸序列与VanC的同源性(55%)比与VanA(45%),VanB(43%)或VanD(44%)更大。这与以下事实一致:BM4405合成了以D-丝氨酸残基终止的肽聚糖前体。万古霉素诱导后,在BM4405的细胞质提取物中检测到弱的D,D-二肽酶活性和对青霉素不敏感的D,D-羧肽酶活性,而在膜制剂中发现了丝氨酸消旋酶活性。这种新型的获得性糖肽耐药性称为VanE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号